Fennec Pharmaceuticals Inc. FRX
Updated: 10 Aug 2026
No signal published yet
We already track Fennec Pharmaceuticals and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.
Email when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Temporary check — not Firelda's published signal.
General analysis — not personal advice.
Want to follow Fennec Pharmaceuticals Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow Fennec Pharmaceuticals free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Recent News
On August 5, 2026, Fennec Pharmaceuticals announced that it will release its second-quarter 2026 financial results on August 11, 2026. In the first quarter of 2026, the company reported net product sales of $15.1 million and held $40.2 million in cash and cash equivalents. The company is actively progressing commercial expansion and broader clinical studies.
What Firelda Watch includes for Fennec Pharmaceuticals Inc.
Add the company to your watchlist and get all of this automatically.
- Free: 3 companies on your watchlist
- Change history and monitoring for every company you follow
- Sunday weekly brief — a short weekly roundup
- Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
Want to follow Fennec Pharmaceuticals Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow Fennec Pharmaceuticals free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more